Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR

Conditions

Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR

Trial Timeline

Dec 1, 2011 → May 1, 2012

About Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)

Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg) is a phase 1 stage product being developed by Yuhan for Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR. The current trial status is completed. This product is registered under clinical trial identifier NCT01526317. Target conditions include Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01526317Phase 1Completed

Competing Products

20 competing products in Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR

See all competitors
ProductCompanyStageHype Score
GP30341 capsules 200 mg + Standard therapyGEROPHARMPre-clinical
15
GP40221 + ozempicGEROPHARMPhase 1
25
Memantinol tablets, 20 mg + Akatinol Memantine® tablets, 20 mgGEROPHARMPhase 1
25
Rinsulin NPH + Humulin NPHGEROPHARMPre-clinical
15
DS-8500a + ItraconazoleDaiichi SankyoPhase 1
33
Milademetan + Itraconazole + PosaconazoleDaiichi SankyoPhase 1
33
Pexidartinib + ProbenecidDaiichi SankyoPhase 1
33
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
33
DS-8500aDaiichi SankyoPhase 1
33
Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment CDaiichi SankyoPhase 1
33
tolterodine + mirabegronAstellas PharmaApproved
85
ASP3652Astellas PharmaPhase 1
33
ASP015K ER + ASP015K IRAstellas PharmaPhase 1
33
YM178 modified release (OCAS) + YM178 immediate release (IR)Astellas PharmaPhase 1
33
Isavuconazole + dextromethorphanAstellas PharmaPhase 1
33
mirabegron + metoprololAstellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
zolbetuximab + oxaliplatin + leucovorin + fluorouracil + Pembrolizumab + folinic acid + nivolumab + DocetaxelAstellas PharmaPhase 2
52
Isavuconazole + Repaglinide + CaffeineAstellas PharmaPhase 1
33
mirabegron + rifampinAstellas PharmaPhase 1
33